Patient’s characteristics before allo-HSCT
| . | No. (%) of cases with available information . | Overall . | LAD type I . | LAD type III . | P . |
|---|---|---|---|---|---|
| N (%) | 84 (100) | 69 (82) | 11 (13) | ||
| Sex, n (%) | 83 (99) | .858 | |||
| Female | 40 (48) | 32 (46) | 6 (55) | ||
| Male | 43 (52) | 37 (54) | 5 (45) | ||
| Age at diagnosis, mo | 84 (100) | .214 | |||
| Median | 3 | 3 | 7 | ||
| IQR | 1-12 | 1-10 | 3-17 | ||
| Range | 0-131 | 0-131 | 0-50 | ||
| Time between diagnosis and allo-HSCT, mo | 84 (100) | ||||
| Median | 7 | 8 | 7 | .442 | |
| IQR | 3-17 | 3-20 | 2-13 | ||
| Range | 1-353 | 1-353 | 1-46 | ||
| Infections before allo-HSCT, n (%) | 51 (61) | .224 | |||
| Yes | 45 (88) | 37 (93) | 7 (78) | ||
| No | 6 (12) | 3 (7) | 2 (22) | ||
| Recurrence of infections before allo-HSCT, n (%) | 32 (71)* | .120 | |||
| Once with 1 infection | 1 (3) | 0 | 1 (33) | ||
| Once with 2 or more simultaneous infections | 21 (66) | 19 (68) | 2 (67) | ||
| Twice with 2 or more simultaneous infections | 8 (25) | 7 (25) | 0 | ||
| More than twice with more simultaneous infections | 2 (6) | 2 (7) | 0 |
| . | No. (%) of cases with available information . | Overall . | LAD type I . | LAD type III . | P . |
|---|---|---|---|---|---|
| N (%) | 84 (100) | 69 (82) | 11 (13) | ||
| Sex, n (%) | 83 (99) | .858 | |||
| Female | 40 (48) | 32 (46) | 6 (55) | ||
| Male | 43 (52) | 37 (54) | 5 (45) | ||
| Age at diagnosis, mo | 84 (100) | .214 | |||
| Median | 3 | 3 | 7 | ||
| IQR | 1-12 | 1-10 | 3-17 | ||
| Range | 0-131 | 0-131 | 0-50 | ||
| Time between diagnosis and allo-HSCT, mo | 84 (100) | ||||
| Median | 7 | 8 | 7 | .442 | |
| IQR | 3-17 | 3-20 | 2-13 | ||
| Range | 1-353 | 1-353 | 1-46 | ||
| Infections before allo-HSCT, n (%) | 51 (61) | .224 | |||
| Yes | 45 (88) | 37 (93) | 7 (78) | ||
| No | 6 (12) | 3 (7) | 2 (22) | ||
| Recurrence of infections before allo-HSCT, n (%) | 32 (71)* | .120 | |||
| Once with 1 infection | 1 (3) | 0 | 1 (33) | ||
| Once with 2 or more simultaneous infections | 21 (66) | 19 (68) | 2 (67) | ||
| Twice with 2 or more simultaneous infections | 8 (25) | 7 (25) | 0 | ||
| More than twice with more simultaneous infections | 2 (6) | 2 (7) | 0 |
IQR, interquartile range.
This percentage corresponds to n = 45 patients with infections.